Cervical insufficiency: a noteworthy disease with controversies
Yu Han1, Mengnan Li2, Huijing Ma2
1Department of First Clinical Medical College, Shanxi Medical University, Taiyuan, P.R. China.
Journal of Perinatal Medicine
|July 22, 2020
Summary
Cervical insufficiency (CI) is a condition causing recurrent pregnancy loss. This review clarifies risk factors, diagnosis, and treatment controversies for cervical insufficiency to aid clinicians and researchers.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Medicine
Background:
- Cervical insufficiency (CI) affects approximately 1% of obstetric populations, leading to recurrent miscarriages and preterm birth.
- CI poses significant economic and psychological burdens due to recurrent pregnancy losses.
- There is widespread confusion regarding CI's etiology, diagnosis, and treatment among patients and clinicians.
Purpose of the Study:
- To summarize potential risk factors associated with cervical insufficiency.
- To review current diagnostic and treatment methods for CI.
- To present recent guidelines, consensus, and controversies surrounding CI.
Main Methods:
- Literature review of potential risk factors for CI.
- Analysis of diagnostic techniques for CI.
- Review of therapeutic interventions and management strategies for CI.
- Examination of updated guidelines and expert consensus on CI.
Main Results:
- Identified potential risk factors warranting further investigation.
- Outlined various diagnostic approaches and their limitations.
- Summarized current treatment options and highlighted areas of controversy.
- Presented updated consensus and debated points from recent guidelines.
Conclusions:
- Further research into CI etiology and risk factors is needed.
- Standardized diagnostic criteria and evidence-based treatment protocols are crucial.
- Addressing controversies and disseminating updated guidelines can improve CI management.
